Glen Santangelo
Stock Analyst at Jefferies
(1.72)
# 2,897
Out of 4,670 analysts
71
Total ratings
45.45%
Success rate
-5.47%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $17.55 | +2.56% | 2 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $15.44 | +55.44% | 4 | Sep 19, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $8 → $10 | $10.62 | -5.84% | 6 | Sep 17, 2024 | |
| VTRS Viatris | Reinstates: Buy | $15 | $13.37 | +12.19% | 3 | Jul 19, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $25.33 | -9.20% | 4 | Jun 27, 2024 | |
| TEVA Teva Pharmaceutical | Maintains: Buy | $19 → $23 | $17.12 | +34.35% | 4 | Jun 27, 2024 | |
| COLL Collegium Pharmaceutical | Upgrades: Buy | $41 → $44 | $29.96 | +46.86% | 3 | Jun 7, 2024 | |
| ELAN Elanco Animal Health | Initiates: Buy | $17 | $13.36 | +27.25% | 1 | Dec 19, 2023 | |
| ZTS Zoetis | Assumes: Buy | $230 | $176.96 | +29.97% | 1 | Dec 19, 2023 | |
| VRCA Verrica Pharmaceuticals | Reiterates: Buy | $10 | $0.99 | +905.53% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $45.46 | +53.98% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $14 | $3.70 | +278.38% | 2 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $5.5 | $0.53 | +929.96% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $4 | $3.09 | +29.45% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $9.34 | +71.31% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $3.35 | +317.91% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5 | $0.48 | +941.67% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $48.20 | -4.56% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $80 | $104.25 | -23.26% | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $8.13 | +244.40% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $19.87 | +252.29% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $8.10 | +1,381.48% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $3.45 | -42.03% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $4.90 | +859.18% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $4.37 | +723.80% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $58.01 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $623.19 | -72.88% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $20.46 | - | 2 | Jan 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $121.84 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $75.08 | +9.22% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $18.77 | +331.54% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $225.89 | +10.67% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $78 | $8.66 | +800.69% | 1 | Dec 4, 2017 |
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $17.55
Upside: +2.56%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $15.44
Upside: +55.44%
Teladoc Health
Sep 17, 2024
Maintains: Hold
Price Target: $8 → $10
Current: $10.62
Upside: -5.84%
Viatris
Jul 19, 2024
Reinstates: Buy
Price Target: $15
Current: $13.37
Upside: +12.19%
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $25.33
Upside: -9.20%
Teva Pharmaceutical
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $17.12
Upside: +34.35%
Collegium Pharmaceutical
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $29.96
Upside: +46.86%
Elanco Animal Health
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $13.36
Upside: +27.25%
Zoetis
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $176.96
Upside: +29.97%
Verrica Pharmaceuticals
Dec 15, 2023
Reiterates: Buy
Price Target: $10
Current: $0.99
Upside: +905.53%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $45.46
Upside: +53.98%
Feb 9, 2023
Downgrades: Hold
Price Target: $14
Current: $3.70
Upside: +278.38%
Oct 21, 2022
Initiates: Hold
Price Target: $5.5
Current: $0.53
Upside: +929.96%
Oct 21, 2022
Assumes: Buy
Price Target: $4
Current: $3.09
Upside: +29.45%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $9.34
Upside: +71.31%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $3.35
Upside: +317.91%
Oct 21, 2022
Assumes: Buy
Price Target: $5
Current: $0.48
Upside: +941.67%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $48.20
Upside: -4.56%
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $104.25
Upside: -23.26%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $8.13
Upside: +244.40%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $19.87
Upside: +252.29%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $8.10
Upside: +1,381.48%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $3.45
Upside: -42.03%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $4.90
Upside: +859.18%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $4.37
Upside: +723.80%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $58.01
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $623.19
Upside: -72.88%
Jan 7, 2020
Upgrades: Buy
Price Target: n/a
Current: $20.46
Upside: -
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $121.84
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $75.08
Upside: +9.22%
Dec 8, 2017
Initiates: Buy
Price Target: $81
Current: $18.77
Upside: +331.54%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $225.89
Upside: +10.67%
Dec 4, 2017
Initiates: Hold
Price Target: $78
Current: $8.66
Upside: +800.69%